Articles Posted in Medical News

by

Over the years, medical advances have led to countless innovative inventions that have saved many lives. However, not every medical innovation lives up to its expectations. The recall of DuPuy’s metal-on-metal hip joint is a perfect example of a medical device that failed to delivery as promised.

The first artificial hip joint was developed in the 1960s and was made of a metal ball placed in a plastic cup, which were meant to replicate the thigh bone and hip socket, respectively. Then, metal-on-metal hip implant devices were developed in response to studies showing that metal and plastic hip devices were leading to bone loss in some patients.

The medical community believed the medical device changes made to metal-on-metal hip implants would revolutionize the future of artificial hips. Not only would the newer design lead to less bone loss in patients, but by replacing plastic with metal, the belief was that the new medical device would last longer than the original metal and plastic version. Medical professionals viewed metal-on-metal hip devices as the final solution to hip implant patients’ problems.

Continue reading

by

France’s Agence Francaise De Securite Sanitaire Des Produits De Sante (AFSSAPS) banned the use of Actors, a drug prescribed to control diabetes, due to concerns that it increases the risk of bladder cancer amongst patients taking the drug. Actors manufactured by Japan’s Takeda Pharmaceutical and is one of the pharmaceutical company’s top-selling drugs. The French medical board’s decision has caused Germany to follow suit in banning the diabetes drug, with reports that the UK might soon follow.

The French drug suspension not only affects Actos, but also applies to Competact, a similar prescription drug that combines Actos with metformin. Both drugs were suspended because they contained the active ingredient Pioglitazone, which has been linked to the increase risk of bladder cancer. This risk was documented in a study of antidiabetic patients taking antidiabetic medicines that was conducted by the Caisse National d’Assurance Maladie between 2006 and 2009.

The sale of Actos was approved in Europe in 2000, with Competact being approved in 2006. Since that time, an estimated 230,000 patients use Actos in France alone. In 2010, Europe accounted for Y29.5 billion, or about 7.5%, of Actos Y387.9 billion in global sales. The banning of Actos in Europe could drastically affect the fate of the Japan-based pharmaceutical company and exposes it to potential pharmaceutical liability lawsuits.

Continue reading

by

Illinois hospitals are required to have an internal review board that conducts investigations that focus on the quality of patient care. These investigations can be triggered by catastrophic outcomes, unexpected deaths, and also by the suggestion of another hospital employee. The purpose of these investigations is to improve the quality of patient care by identifying any potential abuse or medical negligence and then coming up with ways to prevent similar outcomes in the future.

The Illinois Department of Public Health has recently amended its regulations regarding various components of patient abuse and neglect in order to increase patient safety in hospitals. These new regulations fall under the amendments made to 77 Ill. Adm. Code 250 et seq. and have already gone into effect in Illinois.

One of the most valuable tools for identify patient abuse is hospital employees themselves. Hospital employees are aware of what the appropriate standards are for patient care and are in an unique position to identify when abuse does occur. Therefore, many of the new regulations are meant to clarify the process of reporting patient abuse and neglect and putting protections in place for the “whistleblower” employees.

Continue reading

by

The death of a high-power, Chicago executive at the University of Chicago Medical Center could lead to the Chicago hospital losing its medicare payments. James Tyree, CEO of The Chicago Sun-Times and Mesirow Financial, died from an air embolism that developed after his catheter was removed incorrectly. The medical negligence occurred while Mr. Tyree was being treated for pneumonia at the University of Chicago Medical Center.

The air embolism occurred after air entered the catheter as it was being removed. The air bubble then entered Mr. Tyree’s blood stream. This is problematic because when an air bubble becomes lodged in a vein or artery it can eventually block the flow of blood through that vein or artery. If your blood flow is blocked you are at risk of not getting enough blood to your heart or brain, which is a deadly situation.

This fatal medical error was not only preventable, but involved a skill that was so basic its being done incorrectly could be seen as gross negligence. After considering the facts of Mr. Tyree’s death, the Centers for Medicare and Medicaid Services stated that the “deficiencies [which led to Mr. Tyree’s death] were so serious that they constitute an immediate threat to patient health and safety.”

Continue reading

by

Prior to the 1980s, the risk of transmitting HIV through transplanted organs was fairly high, at a time when even blood transfusions put patients at risk for contracting the deadly virus. However, in 1985, HIV antibody testing became available, which enabled doctors and medical staff to test to see whether organs were infected with HIV. Therefore in today’s medical climate it is unlikely that an organ transplant recipient would receive organs infected with HIV.

However, in 2007, four Chicago patients were found to have transmitted HIV by way of their transplanted organs. While the transplant surgeries were done at three different Chicago Hospitals, each of the four patients received organs from the same organ donor. At the time of the transplant surgery the donor was not known to be infected with HIV. His organs passed the standard tests for HIV antibodies; however, those tests could not have detected HIV if the donor acquired the infection within a few weeks of his death.

Critics of the way these 2007 transplant surgeries were handled argue that a nucleic acid test could have detected the HIV infection earlier. However, the nucleic acid test was not approved by the FDA until 2009 and even today is not effective 100 percent of the time; too many false positives make the nucleic acid test unreliable as an universal screening tool.

Continue reading

by

Radiation therapy is a common treatment for a large range of cancers and has been responsible for saving, or at least extending, many peoples’ lives. However, the basic premise of radiation therapy involves targeting and killing cancerous cells in one’s body. And while properly administered radiation therapy can save lives, when hospitals and doctors administer too much radiation it can result in negative effects for the treating patient.

Overdoses of radiation is becoming more and more widespread amongst cancer patients. A recent report of Evanston’s Northshore University HealthSystem, a Chicago-area hospital, provided one such example. A 50 year-old mother of three was administered dangerously high doses of radiation when the hospital staff made radiology errors involving the administration of her radiation doses. The young Illinois resident went from an active, vibrant person pre-radiation to a virtual invalid post-radiation and now resides in an Illinois nursing home.

This woman was just one of three oncology patients who received an overdose of radiation at Evanston Hospital. All three instances of the radiation errors were allegedly the result of faulty linear particle accelerators. These accelerators are used to focus the radiation on the cancerous cells and are commonly used for stereotactic radiosurgery (SRS).

Continue reading

by

Nine years ago Josie King lost her 18-month-old daughter as a result of medical negligence. She has since turned this tragedy into something positive, as she has become a major advocate in the prevention of further medical negligence. King has used her own personal experiences to become a voice in the fight for better communication among hospitals and doctors.

King’s daughter was being treated at John Hopkins Hospital for severe burns when she received a methadone shot that resulted in her brain death. The medical negligence in King’s case was due to the fact that her daughter was not meant to get the shot – the doctor had cancelled the order for it, but a nurse gave it to King’s daughter anyway.

The King family brought a medical malpractice lawsuit against the hospital and have used the settlement they received to start the Josie King Foundation in memory of their daughter. This foundation focuses on increasing patient safety programs in hospitals and doctor offices.

Continue reading

by

A recently published government report has sparked additional concerns regarding the risk of overexposure to radiation from unnecessary radiology scans. The results of the national report on medical imaging practices shows that Illinois hospitals provide double chest CT scans almost twice as often as other hospitals nationwide. A double chest CT scan is when a study is ordered both with and without contrast, which requires it to be done twice thereby exposing the patient to twice as much radiation.

One of the main hospitals cited in the report as potentially giving “patients a double scan when a single scan is all they need” is Edward Hospital, located in Naperville, Illinois. Edward Hospital officials were reportedly surprised to learn that their CT scans exceeded the national average and have since launched an investigation into its radiology department policies and procedures.

The new government reports on Edward Hospital and other medical institutions nationwide can be found at the government-run website Hospital Compare. This informative website allows patients to search different hospitals by region and compare the quality of care provided by each. Medical information websites like Hospital Compare allow patients to be their own medical advocate and make informed decisions about their care and treatment.

Continue reading

by

Breast cancer is one of the most common forms of cancer for American women, coming in just second behind lung cancer. According to www.breastcancer.org, one in every eight women in the U.S. develops some form of breast cancer. Like any form of cancer, a delay in diagnosis or a misdiagnosis of cancer can have a negative effect on a patient’s outcome.

Once breast cancer is diagnosed, the typical treatment for breast cancer involves surgery, chemotherapy, and radiation. However, a new study unveiled at a Chicago meeting of the American Society of Clinical Oncology (ASCO) could change the standard for breast cancer treatment. TARGIT-A study is an international study of breast cancer clinical trials involving over 2,000 breast cancer patients. The participants were women 45 years-old and up who had been diagnosed with invasive ductal breast cancer and were undergoing breast-conserving surgery.

Traditionally patients who elect for breast-conserving surgery undergo whole breast external radiation therapy for up to 6 1/2 weeks following surgery. However, the TARGIT-A clinical trials studied the effects of targeted radiation administered during the surgery. The radiation is administered in a single dose and targets only the area of the breast with cancer instead of the whole breast. Half of the studies participants underwent the traditional post-op radiation while the other half received the targeted radiation therapy during surgery. The TARGIT-A study found that the targeted therapy group did somewhat better overall than the traditional radiation group.

Continue reading

by

In an effort to find new ways to stop tumors from growing, scientists are researching ways to develop drugs that will stop blood vessels from growing. The first step to developing these complex drugs is to identify the human genes that are essential for blood vessel growth, something that researchers at the University of Austin were able to do by using the new branch of biology known as deep homology.

The study’s results, published in The Proceedings of the National Academy of Sciences, revealed that these scientists were able to identify five different human genes that were essential for blood vessel growth. The hope is that by developing a drug that would halt these genes from working we would have a new tool in the fight against cancer.

And while the results of the study are remarkable, what is perhaps even more amazing is the way these scientists isolated these human genes. The researchers first identified the blood vessel growing genes by discovering that the same genes work at building cell walls in yeast. The same group of scientists is responsible for finding the genes associated with deafness by studying plants and the genes associated with breast cancer by studying nematode worms.

Continue reading